Dynamic Advisor Solutions LLC Ocugen, Inc. Transaction History

Dynamic Advisor Solutions LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	BUY	$0.82 - $1.33 $7,216 - $11,704	8,800 Added 41.45%	30,030 $25,000
Q3 2022 Oct 20, 2022	SELL	$1.75 - $3.1 $7,350 - $13,020	-4,200 Reduced 16.52%	21,230 $38,000
Q2 2022 Jul 27, 2022	SELL	$1.83 - $3.45 $10,614 - $20,010	-5,800 Reduced 18.57%	25,430 $58,000
Q1 2022 Apr 11, 2022	BUY	$2.34 - $4.72 $40,248 - $81,184	17,200 Added 122.59%	31,230 $103,000
Q4 2021 Jan 26, 2022	SELL	$4.38 - $15.67 $30,528 - $109,219	-6,970 Reduced 33.19%	14,030 $64,000
Q3 2021 Oct 28, 2021	BUY	$6.36 - $8.51 $50,880 - $68,080	8,000 Added 61.54%	21,000 $151,000
Q2 2021 Aug 10, 2021	BUY	$5.52 - $15.68 $71,760 - $203,840	13,000 New	13,000 $104,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.